Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.

Literature DB >> 17546486

Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.

Anna Kezerashvili¹, Himad Khattak, Aron Barsky, Reza Nazari, John D Fisher.

Abstract

During treatment with azithromycin, a 55 year-old woman developed a newly prolonged QT interval and torsade de pointes in the absence of known risk factors. Female gender and acute renal failure may be considerations in patients treated with azithromycin.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2007 PMID： 17546486 DOI： 10.1007/s10840-007-9124-y

Source DB: PubMed Journal: J Interv Card Electrophysiol ISSN： 1383-875X Impact factor: 1.900

18 in total

1. [Torsade de pointes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome].

Authors: E Arellano-Rodrigo; A García; L Mont; M Roqué
Journal: Med Clin (Barc) Date: 2001-06-23 Impact factor: 1.725

Review 2. Comparative safety of the different macrolides.

Authors: E Rubinstein
Journal: Int J Antimicrob Agents Date: 2001 Impact factor: 5.283

3. A case of QT-interval prolongation precipitated by azithromycin.

Authors: Naohisa Matsunaga; Yasuhiro Oki; Alejandro Prigollini
Journal: N Z Med J Date: 2003-11-07

4. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.

Authors: Lars Eckardt; Günter Breithardt; Wilhelm Haverkamp
Journal: J Pharmacol Exp Ther Date: 2002-01 Impact factor: 4.030

5. Is azithromycin treatment associated with prolongation of the Q-Tc interval?

Authors: Franc Strle; Vera Maraspin
Journal: Wien Klin Wochenschr Date: 2002-06-14 Impact factor: 1.704

6. Impact of haemodialysis on QTc dispersion in children.

Authors: Durgul Ozdemir; Timur Mese; Hasan Agin; Sebnem Calkavur; Mustafa Bak
Journal: Nephrology (Carlton) Date: 2005-04 Impact factor: 2.506

7. QT prolongation associated with azithromycin/amiodarone combination.

Authors: P Samarendra; S Kumari; S J Evans; T J Sacchi; V Navarro
Journal: Pacing Clin Electrophysiol Date: 2001-10 Impact factor: 1.976

8. QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion.

Authors: C E Bonnar; A P Davie; L Caruana; L Fenn; S A Ogston; J J McMurray; A D Struthers
Journal: Heart Date: 1999-03 Impact factor: 5.994

9. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.

Authors: Peter Milberg; Lars Eckardt; Hans-Jürgen Bruns; Julia Biertz; Shahram Ramtin; Nico Reinsch; Dirk Fleischer; Paulus Kirchhof; Larissa Fabritz; Günter Breithardt; Wilhelm Haverkamp
Journal: J Pharmacol Exp Ther Date: 2002-10 Impact factor: 4.030

Review 10. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review.

Authors: M W Brandriss; W S Richardson; S S Barold
Journal: Clin Infect Dis Date: 1994-06 Impact factor: 9.079

41 in total

1. Azithromycin and the risk of cardiovascular death.

Authors: Wayne A Ray; Katherine T Murray; Kathi Hall; Patrick G Arbogast; C Michael Stein
Journal: N Engl J Med Date: 2012-05-17 Impact factor: 91.245

2. Azithromycin Causes a Novel Proarrhythmic Syndrome.

Authors: Zhenjiang Yang; Joseph K Prinsen; Kevin R Bersell; Wangzhen Shen; Liudmila Yermalitskaya; Tatiana Sidorova; Paula B Luis; Lynn Hall; Wei Zhang; Liping Du; Ginger Milne; Patrick Tucker; Alfred L George; Courtney M Campbell; Robert A Pickett; Christian M Shaffer; Nagesh Chopra; Tao Yang; Bjorn C Knollmann; Dan M Roden; Katherine T Murray
Journal: Circ Arrhythm Electrophysiol Date: 2017-04

Review 3. Gastroparesis: current diagnostic challenges and management considerations.

Authors: Shamaila Waseem; Baharak Moshiree; Peter V Draganov
Journal: World J Gastroenterol Date: 2009-01-07 Impact factor: 5.742

4. Should azithromycin no longer be considered a drug of choice for community-acquired pneumonia because of its potential to cause cardiovascular death?

Authors:
Journal: Can J Hosp Pharm Date: 2013-09

5. Giant inverted T waves and substantial QT interval prolongation induced by azithromycin in an elderly woman with renal insufficiency.

Authors: Tongtong Yu; Tiesheng Niu
Journal: Can Fam Physician Date: 2014-11 Impact factor: 3.275

Review 6. Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.

Authors: Arsen Uvelin; Jasmina Pejaković; Vesna Mijatović
Journal: J Anesth Date: 2017-02-22 Impact factor: 2.078

7. Use of azithromycin and risk of ventricular arrhythmia.

Authors: Gianluca Trifirò; Maria de Ridder; Janet Sultana; Alessandro Oteri; Peter Rijnbeek; Serena Pecchioli; Giampiero Mazzaglia; Irene Bezemer; Edeltraut Garbe; Tania Schink; Elisabetta Poluzzi; Trine Frøslev; Mariam Molokhia; Igor Diemberger; Miriam C J M Sturkenboom
Journal: CMAJ Date: 2017-04-18 Impact factor: 8.262